paperKB
coga / coga-kb
Help
Sign in

rs16969968 risk_factor_for lung cancer

Subject
rs16969968
Relation
risk_factor_for
Object
lung cancer
p-value
0.001
Evidence from: primary | all sources

Evidence (8 sources)

Human Genetics of Addiction: New Insights and Future Directions. (2018) PMID:29504045 cited
high-risk rs16969968-AA genotype was associated with a 4-year earlier median age of lung cancer diagnosis
confidence: 0.93
The genetic basis of addictive disorders. (2012) PMID:22640768 cited
The Asn398 allele ... increased susceptibility to develop lung cancer.
confidence: 0.90
Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. (2011) PMID:21862624 cited
Both rs16969968 (OR=1.31, 95%CI 1.16-1.48, P<0.001) ... were associated with risk ...
confidence: 0.96
Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. (2011) PMID:21862624 cited
In current smokers rs16969968 increased lung cancer risk (OR=1.39, P<0.001) and in former smokers (OR=1.31, P=0.01).
confidence: 0.95
Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. (2010) PMID:19896728 cited
The variant CHRNA5 (D398N), which greatly increases the risk for ... lung cancer ...
confidence: 0.96
Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. (2010) PMID:19896728 cited
the polymorphism likely has a direct role in the etiology of lung cancer
confidence: 0.90
The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. (2009) PMID:19706762 cited
Genome-wide studies of lung cancer report strong association with rs16969968 ...
confidence: 0.95
The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. (2009) PMID:19706762 cited
rs16969968 ... is clearly implicated in risk for ... lung cancer in individuals of European descent
confidence: 0.95